GLAXO OPERATIONS UK LIMITED – MIA 4
| Authorisation Number | UK MIA 4 |
| Category | MIA |
| Holder | GLAXO OPERATIONS UK LIMITED |
| Registered Address | GLAXO OPERATIONS UK LIMITED, 79 NEW OXFORD STREET, LONDON, WC1A 1DG, UNITED KINGDOM |
| Authorisation Date | May 20, 2026 |
| Legal Basis | HumanRegulation 17 of The Human Medicines Regulations 2012 (SI 2012/1916) |
| Sites | 2 |
| Manufacturing Operations | 1.1 1.1.1 1.1.1.4 1.1.2 1.1.2.3 1.1.2.5 1.1.3 1.2 1.2.1 1.2.1.1 1.2.1.11 1.2.1.13 1.2.1.17 1.2.1.6 1.2.1.8 1.2.2 1.3 1.3.1 1.3.1.2 1.3.1.5 1.3.1.8 1.3.2 1.3.2.2 1.3.2.5 1.3.2.8 1.4 1.4.1 1.4.1.3 1.4.2 1.4.2.1 1.4.2.3 1.5 1.5.1 1.5.1.1 1.5.1.11 1.5.1.13 1.5.1.17 1.5.1.6 1.5.1.8 1.5.2 1.6 1.6.1 1.6.2 1.6.3 1.6.4 |
| Importation Operations | 2.3 2.3.2 2.3.3 |
| MHRA Link | View on MHRA Website |
Sites (2)
GLAXO OPERATIONS UK LTD TRADING AS GLAXO WELLCOME OPERATIONS
MANUFACTURING_SITE
Country: UNITED KINGDOMProduct Class: Human Medicinal Products
Manufacturing
1.2 — Non-sterile products
1.2.1 — Non-Sterile Products (processing operations for the following dosage forms)
1.2.1.1 — Capsules, hard shell
1.2.1.8 — Other solid dosage forms
1.2.1.13 — Tablets
1.2.1.17 — Other non-sterile medicinal products
1.3 — Biological medicinal products
1.3.1 — Biological medicinal products
1.3.1.8 — Other biological medicinal products
1.4 — Other products or manufacturing activity
1.4.1 — Manufacture of:
1.4.1.3 — Other
1.5 — Packaging
1.5.1 — Primary packaging
1.5.1.1 — Capsules, hard shell
1.5.1.8 — Other solid dosage forms
1.5.1.13 — Tablets
1.5.1.17 — Other non-sterile medicinal products
1.5.2 — Secondary packaging
1.6 — Quality control testing
1.6.2 — Microbiological: non-sterility
1.6.3 — Chemical/Physical
GLAXO OPERATIONS UK LTD TRADING AS GLAXO WELLCOME OPERATIONS
BOTH
Country: UNITED KINGDOMProduct Class: Human Medicinal Products
Manufacturing
1.1 — Sterile Products
1.1.1 — Aseptically prepared (processing operations for the following dosage forms)
1.1.1.4 — Small volume liquids
1.1.2 — Terminally Sterilised (processing operations for the following dosage forms)
1.1.2.3 — Small volume liquids
1.1.2.5 — Other terminally sterilised prepared products
1.1.3 — Batch certification
1.2 — Non-sterile products
1.2.1 — Non-Sterile Products (processing operations for the following dosage forms)
1.2.1.6 — Liquids for internal use
1.2.1.11 — Semi-solids
1.2.1.17 — Other non-sterile medicinal products
1.2.2 — Batch certification
1.3 — Biological medicinal products
1.3.1 — Biological medicinal products
1.3.1.2 — Immunological products
1.3.1.5 — Biotechnology products
1.3.1.8 — Other biological medicinal products
1.3.2 — Batch certification
1.3.2.2 — Immunological products
1.3.2.5 — Biotechnology products
1.3.2.8 — Other biological medicinal products
1.4 — Other products or manufacturing activity
1.4.2 — Sterilisation of active substances/excipients/finished products:
1.4.2.1 — Filtration
1.4.2.3 — Moist heat
1.5 — Packaging
1.5.1 — Primary packaging
1.5.1.6 — Liquids for internal use
1.5.1.11 — Semi-solids
1.5.1.17 — Other non-sterile medicinal products
1.5.2 — Secondary packaging
1.6 — Quality control testing
1.6.1 — Microbiological: sterility
1.6.2 — Microbiological: non-sterility
1.6.3 — Chemical/Physical
1.6.4 — Biological
Importation
2.3 — Other Importation Activities
2.3.2 — Importation of Intermediate which undergoes further processing
2.3.3 — Biological Active Substance
Content Preview
The source document is available on KeyPedia. Sign in to view.